1.
|
Phase: Phase III, Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: BR18, CAN-NCIC-BR18, BMS-CA161-003, CDR0000068153, NCT00006229
|
|
2.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 16 and over Sponsor: NCI Protocol IDs: NCI-2012-02410, AMC-024, CPMC-IRB-13985, CDR0000068885, NCT00024024
|
|
3.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2012-02799, MC0151, N01CM17104, CDR0000069352, MAYO-MC0151, NCI-5361, 5361, NCT00039104
|
|
4.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2013-00041, PHII-32, N01CM17101, N01CM17102, CDR0000069402, UCD-CHNMC-PHII-32, CHNMC-PHII-32, NCI-5615, 5615, NCT00040755
|